Xspray Pharma extends SEK 74.6 million Fenja loan to August 2028

Bitget2026/11/06 07:06

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Xspray Pharma extended its SEK 74.6 million loan with Fenja Capital II to August 15, 2028.
The loan must be reduced to SEK 50 million by January 5, 2027; Fenja waived certain loan provisions.
Fenja's existing 1,175,000 warrants will be canceled and replaced free of charge with five-year Warrants 2026:2 carrying a SEK 13.30 exercise price.
The replacement warrants represent approximately 2.5% dilution following the rights issue and any over-allotment issue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XSpray Pharma AB (publ) published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Xspray Pharma extends SEK 74.6 million Fenja loan to August 2028

You may also like

Crypto prices